Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AstraZeneca PLC stock logo
AZN
AstraZeneca
$71.15
-2.3%
$79.77
$60.47
$87.68
$220.61B0.465.03 million shs7.41 million shs
AstraZeneca PLC stock logo
AZN
AstraZeneca
$71.15
-2.3%
$79.77
$60.47
$87.68
$220.61B0.465.03 million shs7.41 million shs
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
$141.90
-5.1%
$158.28
$118.16
$175.00
N/AN/A2,711 shs1,307 shs
Intuit Inc. stock logo
INTU
Intuit
$610.30
-1.7%
$623.98
$481.94
$676.62
$170.61B1.241.32 million shs1.48 million shs
Super Group Limited stock logo
SGHC
Super Group
$4.10
-1.2%
$3.72
$2.63
$4.25
$2.04B0.71409,316 shs344,263 shs
Wix.com Ltd. stock logo
WIX
Wix.com
$167.12
-0.5%
$163.28
$76.90
$179.00
$9.55B1.48545,598 shs313,169 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AstraZeneca PLC stock logo
AZN
AstraZeneca
-3.18%-5.35%-6.52%-10.31%+15.18%
AstraZeneca PLC stock logo
AZN
AstraZeneca
-3.18%-5.35%-6.52%-10.31%+15.18%
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
-0.10%-1.86%-3.21%-6.91%+21.78%
Intuit Inc. stock logo
INTU
Intuit
-0.42%+3.17%+0.02%-2.62%+25.49%
Super Group Limited stock logo
SGHC
Super Group
-0.72%+0.48%+14.33%+10.08%+8.36%
Wix.com Ltd. stock logo
WIX
Wix.com
-1.01%+2.29%+0.42%+13.49%+110.11%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AstraZeneca PLC stock logo
AZN
AstraZeneca
4.5009 of 5 stars
3.55.02.50.03.00.03.1
AstraZeneca PLC stock logo
AZN
AstraZeneca
4.5009 of 5 stars
3.55.02.50.03.00.03.1
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
0.2885 of 5 stars
0.02.01.70.01.20.80.0
Intuit Inc. stock logo
INTU
Intuit
4.8632 of 5 stars
3.43.03.33.02.02.52.5
Super Group Limited stock logo
SGHC
Super Group
4.4588 of 5 stars
3.55.01.70.03.90.82.5
Wix.com Ltd. stock logo
WIX
Wix.com
4.5211 of 5 stars
3.42.00.02.62.21.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AstraZeneca PLC stock logo
AZN
AstraZeneca
2.91
Moderate Buy$89.7526.14% Upside
AstraZeneca PLC stock logo
AZN
AstraZeneca
2.91
Moderate Buy$89.7526.14% Upside
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
N/AN/AN/AN/A
Intuit Inc. stock logo
INTU
Intuit
2.78
Moderate Buy$735.7120.55% Upside
Super Group Limited stock logo
SGHC
Super Group
3.00
Buy$5.5034.15% Upside
Wix.com Ltd. stock logo
WIX
Wix.com
2.89
Moderate Buy$190.0613.73% Upside

Current Analyst Ratings

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00
10/1/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$186.00 ➝ $184.00
9/30/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00
9/27/2024
Intuit Inc. stock logo
INTU
Intuit
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$768.00 ➝ $768.00
9/23/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$200.00 ➝ $200.00
9/23/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight$184.00 ➝ $200.00
9/13/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell
9/13/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell
9/11/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
9/11/2024
AstraZeneca PLC stock logo
AZN
AstraZeneca
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
9/5/2024
Wix.com Ltd. stock logo
WIX
Wix.com
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$200.00
(Data available from 10/31/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AstraZeneca PLC stock logo
AZN
AstraZeneca
$49.13B4.49$5.12 per share13.91$12.63 per share5.63
AstraZeneca PLC stock logo
AZN
AstraZeneca
$49.13B4.49$5.12 per share13.91$12.63 per share5.63
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
N/AN/AN/AN/AN/AN/A
Intuit Inc. stock logo
INTU
Intuit
$16.29B10.48$14.60 per share41.81$65.77 per share9.28
Super Group Limited stock logo
SGHC
Super Group
$1.51B1.35$0.29 per share14.02$1.17 per share3.50
Wix.com Ltd. stock logo
WIX
Wix.com
$1.65B5.78$1.32 per share126.32($0.95) per share-175.92

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AstraZeneca PLC stock logo
AZN
AstraZeneca
$5.96B$2.0734.3715.071.3913.11%29.34%11.15%11/12/2024 (Confirmed)
AstraZeneca PLC stock logo
AZN
AstraZeneca
$5.96B$2.0734.3715.071.3913.11%29.34%11.15%11/12/2024 (Confirmed)
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
N/A$0.82173.90N/AN/AN/AN/AN/A
Intuit Inc. stock logo
INTU
Intuit
$2.96B$10.8458.4037.932.9818.19%18.64%10.87%11/26/2024 (Estimated)
Super Group Limited stock logo
SGHC
Super Group
-$11.42M$0.0668.339.11N/A2.42%12.17%7.16%11/6/2024 (Confirmed)
Wix.com Ltd. stock logo
WIX
Wix.com
$33.14M$1.14132.6450.043.494.44%-49.05%4.78%11/20/2024 (Confirmed)

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/20/2024N/A
Wix.com Ltd. stock logo
WIX
Wix.com
$1.4420N/A-$1.4420N/AN/AN/A
11/12/2024N/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
$1.02N/A-$1.02N/AN/AN/A
11/12/2024N/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
$1.02N/A-$1.02N/AN/AN/A
11/6/2024N/A
Super Group Limited stock logo
SGHC
Super Group
$0.08N/A-$0.08N/AN/AN/A  
8/22/2024Q4 2024
Intuit Inc. stock logo
INTU
Intuit
$1.85$1.99+$0.14$1.29$3.08 billion$3.18 billion    
8/7/2024Q2 2024
Super Group Limited stock logo
SGHC
Super Group
$0.11$0.08-$0.03$0.16$436.89 million$446.44 million
8/7/2024Q2 2024
Wix.com Ltd. stock logo
WIX
Wix.com
$1.32$1.67+$0.35$0.68$442.88 million$435.70 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AstraZeneca PLC stock logo
AZN
AstraZeneca
$0.981.38%+1.18%47.34%N/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
$0.981.38%+1.18%47.34%N/A
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
$2.801.97%N/A343.14%N/A
Intuit Inc. stock logo
INTU
Intuit
$4.160.68%+14.12%38.38%12 Years
Super Group Limited stock logo
SGHC
Super Group
$0.102.44%N/A166.67%N/A
Wix.com Ltd. stock logo
WIX
Wix.com
N/AN/AN/AN/AN/A

Latest AZN, SGHC, WIX, INTU, AZN, and AZNCF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/20/2024
Intuit Inc. stock logo
INTU
Intuit
Quarterly$1.040.67%10/10/202410/10/202410/18/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AstraZeneca PLC stock logo
AZN
AstraZeneca
0.69
0.89
0.69
AstraZeneca PLC stock logo
AZN
AstraZeneca
0.69
0.89
0.69
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
N/AN/AN/A
Intuit Inc. stock logo
INTU
Intuit
0.30
1.29
1.29
Super Group Limited stock logo
SGHC
Super Group
N/A
1.35
1.35
Wix.com Ltd. stock logo
WIX
Wix.com
N/A
1.09
1.09

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AstraZeneca PLC stock logo
AZN
AstraZeneca
20.35%
AstraZeneca PLC stock logo
AZN
AstraZeneca
20.35%
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
40.87%
Intuit Inc. stock logo
INTU
Intuit
83.66%
Super Group Limited stock logo
SGHC
Super Group
5.09%
Wix.com Ltd. stock logo
WIX
Wix.com
81.52%

Insider Ownership

CompanyInsider Ownership
AstraZeneca PLC stock logo
AZN
AstraZeneca
N/A
AstraZeneca PLC stock logo
AZN
AstraZeneca
N/A
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
N/A
Intuit Inc. stock logo
INTU
Intuit
2.90%
Super Group Limited stock logo
SGHC
Super Group
10.41%
Wix.com Ltd. stock logo
WIX
Wix.com
6.20%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AstraZeneca PLC stock logo
AZN
AstraZeneca
89,9003.10 billionN/AOptionable
AstraZeneca PLC stock logo
AZN
AstraZeneca
89,9003.10 billionN/AOptionable
AstraZeneca PLC stock logo
AZNCF
AstraZeneca
83,500N/AN/ANot Optionable
Intuit Inc. stock logo
INTU
Intuit
18,800279.55 million272.16 millionOptionable
Super Group Limited stock logo
SGHC
Super Group
3,700497.94 million446.10 millionOptionable
Wix.com Ltd. stock logo
WIX
Wix.com
4,60057.17 million51.42 millionOptionable

AZN, SGHC, WIX, INTU, AZN, and AZNCF Headlines

Recent News About These Companies

Wix to Announce Third Quarter 2024 Results on November 20, 2024
Wix.com Ltd. (NASDAQ:WIX) Receives $190.06 Consensus PT from Brokerages
Wix.com Ltd (WIX) Trading Down 3.8% on Oct 22
Wix.com Ltd. stock logo
Swedbank AB Trims Stake in Wix.com Ltd. (NASDAQ:WIX)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Company Descriptions

AstraZeneca logo

AstraZeneca

NASDAQ:AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca logo

AstraZeneca

NASDAQ:AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
AstraZeneca logo

AstraZeneca

OTCMKTS:AZNCF
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Intuit logo

Intuit

NASDAQ:INTU
Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProTax. The Small Business & Self-Employed segment provides QuickBooks services, that includes financial and business management online services and desktop software, payroll solutions, time tracking, merchant payment processing solutions, and financing for small businesses; and Mailchimp services, such as e-commerce, marketing automation, and customer relationship management. This segment also offers QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; and QuickBooks Self-Employed solution; payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; and financial supplies and financing for small businesses, as well as electronic filing of federal and state income tax returns. The Consumer segment provides TurboTax income tax preparation products and services. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProTax segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.
Super Group logo

Super Group

NYSE:SGHC
Super Group (SGHC) Limited operates as an online sports betting and gaming operator. It offers Betway, an online sports betting brand; and Spin, a multi-brand online casino offering. Super Group (SGHC) Limited is based in Saint Peter Port, Guernsey.
Wix.com logo

Wix.com

NASDAQ:WIX
Wix.com Ltd., together with its subsidiaries, operates as a cloud-based web development platform for registered users and creators worldwide. The company offers Wix Editor, a drag-and-drop visual development and website editing environment platform; and Wix ADI that enables users to have the freedom of customization that the classic editor offers. It also provides Wix Logo Maker that generates a logo, including through the use of artificial intelligence; Wix Answers to support users; and Payments by Wix, a payment platform, which helps its users receive payments from their customers through their Wix Website. In addition, the company offers various vertical-specific applications that business owners use to operate various aspects of their business online. Further, it provides a range of complementary services, including Wix App Market, a marketplace that offers its registered users various free and paid web applications for building, growing, and managing their businesses; Wix marketplace that brings users seeking help in creating and managing a website together with Web experts; and Wix owner App, a native mobile application, which enables users to manage their Websites and Wix operating systems. The company was formerly known as Wixpress Ltd. The company was incorporated in 2006 and is headquartered in Tel Aviv, Israel.